Nefzi Faten, Lambert Claude, Gautheret-Dejean Agnès, Fisson Sylvain, Khebizi Quentin, Khelif Abderrahim, Agut Henri, Aouni Mahjoub
Laboratory of Transmissible Diseases and Biological Active Substances, LR99ES27, Faculty of Pharmacy, University of Monastir, Street Avicenne 5000, Monastir, Tunisia.
Immunology Laboratory, Georges Friedel Laboratory (CNRS UMR5307); University Hospital of Saint-Étienne, 44 Rue Pointe Cadet, 42100 Saint-Étienne, France.
Microbiol Immunol. 2016 Nov;60(11):770-777. doi: 10.1111/1348-0421.12452.
Primary infection with human herpesvirus-6 (HHV-6), is followed by its lifelong persistence in the host. Most T-cell responses to HHV-6 have been characterized using peripheral blood from healthy adults; however, the role of HHV-6 infection in immune modulation has not been elucidated for some diseases. Therefore, in this study the immune response to HHV-6 infection in patients with B-acute lymphoblastic leukemia (B-ALL) was analyzed. HHV-6 load was quantified in blood samples taken at the time of diagnosis of leukemia and on remission. The same concentrations of anti- and pro-inflammatory cytokines (IL-4, IL-1, IL-6, IL-8, IL-12p70, IL-17a, TNF-α and IFN-γ) were detected in plasma samples from 20 patients with and 20 without detectable HHV-6 virus loads in blood. Characterization of T-cell responses to HHV-6 showed low specific T-cells frequencies of 2.08% and 1.46% in patients with and without detectable viral loads, respectively. IFN-γ-producing T cells were detected in 0.03%-0.23% and in 0%-0.2% of CD4+T cells, respectively. Strong production of IL-6 was detected in medium supernatants of challenged T-cells whatever the HHV-6 status of the patients (973.51 ± 210.06 versus 825.70 ± 210.81 pg/mL). However, concentrations of TNF-α and IFN-γ were low. Thus, no association between plasma concentrations of cytokines and detection of HHV-6 in blood was identified, suggesting that HHV-6 is not strongly associated with development of B-ALL. The low viral loads detected may correspond with latently infected cells. Alternatively, HHV-6B specific immune responses may be below the detection threshold of the assays used.
人类疱疹病毒6型(HHV-6)的初次感染之后会在宿主体内终生持续存在。大多数针对HHV-6的T细胞反应是利用健康成年人的外周血进行表征的;然而,对于某些疾病,HHV-6感染在免疫调节中的作用尚未阐明。因此,在本研究中,分析了B-急性淋巴细胞白血病(B-ALL)患者对HHV-6感染的免疫反应。在白血病诊断时和缓解期采集的血样中对HHV-6载量进行了定量。在20例血液中可检测到HHV-6病毒载量的患者和20例未检测到该病毒载量的患者的血浆样本中,检测到相同浓度的抗炎和促炎细胞因子(IL-4、IL-1、IL-6、IL-8、IL-12p70、IL-17a、TNF-α和IFN-γ)。对HHV-6的T细胞反应表征显示:在可检测到和未检测到病毒载量的患者中,特异性T细胞频率分别较低,为2.08%和1.46%。分别在0.03%-0.23%和0%-0.2%的CD4+T细胞中检测到产生IFN-γ的T细胞。无论患者的HHV-6状态如何,在受刺激的T细胞的培养基上清液中均检测到IL-6的大量产生(973.51±210.06对825.70±210.81 pg/mL)。然而,TNF-α和IFN-γ的浓度较低。因此,未发现细胞因子的血浆浓度与血液中HHV-6的检测之间存在关联,这表明HHV-6与B-ALL的发生没有密切关联。检测到的低病毒载量可能与潜伏感染的细胞相对应。或者,HHV-6B特异性免疫反应可能低于所用检测方法的检测阈值。